Bioäquivalenz von L-Thyroxin-Tabletten und L-Thyroxin-Tropfen bei der Behandlung der Hypothyreose in der täglichen Praxis

[1]  G. Kahaly,et al.  Bioäquivalenz eines Kombinationspräparates aus Levothyroxin und Jodid im Vergleich zum Monopräparat Levothyroxin , 1998, Medizinische Klinik.

[2]  A. Grüters,et al.  The Use of L-T4 as Liquid Solution Improves the Practicability and Individualized Dosage in Newborns and Infants with Congenital Hypothyroidism , 2004, Journal of pediatric endocrinology & metabolism : JPEM.

[3]  F. Dekker,et al.  Neonatal Thyroxine Supplementation in Very Preterm Children: Developmental Outcome Evaluated at Early School Age , 2001, Pediatrics.

[4]  A. Toft.  Thyroid hormone replacement--one hormone or two? , 1999, The New England journal of medicine.

[5]  H. Gharib,et al.  Thyroxine Suppressive Therapy in Patients with Nodular Thyroid Disease , 1998, Annals of Internal Medicine.

[6]  P. Czernichow,et al.  A thyroxine dosage of 8 μg/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism , 1997, European Journal of Pediatrics.

[7]  F. Dekker,et al.  Effects of thyroxine supplementation on neurologic development in infants born at less than 30 weeks' gestation. , 1997, The New England journal of medicine.

[8]  P. Czernichow,et al.  A thyroxine dosage of 8 micrograms/kg per day is appropriate for the initial treatment of the majority of infants with congenital hypothyroidism. , 1997, European journal of pediatrics.

[9]  J. Pinto-Martin,et al.  The relation of transient hypothyroxinemia in preterm infants to neurologic development at two years of age. , 1996, The New England journal of medicine.

[10]  R. Ehrlich,et al.  Long-term effects of L-thyroxine therapy for congenital hypothyroidism. , 1995, The Journal of pediatrics.

[11]  A. Toft.  Thyroxine therapy. , 1994, The New England journal of medicine.

[12]  D. Chassard,et al.  Comparative bioequivalence study of a new levothyroxine solution versus a reference L-thyroxine solution in normal healthy volunteers. , 1991, European journal of drug metabolism and pharmacokinetics.

[13]  J. Cavanaugh,et al.  Replacement dose, metabolism, and bioavailability of levothyroxine in the treatment of hypothyroidism. Role of triiodothyronine in pituitary feedback in humans. , 1987, The New England journal of medicine.

[14]  J. Hennessey,et al.  The equivalency of two L-thyroxine preparations. , 1985, Annals of internal medicine.

[15]  M. Surks,et al.  Oral thyroxine: variation in biologic action and tablet content. , 1984, Annals of internal medicine.